(Q46069718)

19 December 2017

title

Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden (English)

1 reference

19 December 2017

0 references

1

Per-Uno Malmström

1 reference

19 December 2017

author name string

Hans Hedelin

2

1 reference

19 December 2017

Yngvil Kloster Thomas

3

1 reference

19 December 2017

Gwilym J Thompson

4

1 reference

19 December 2017

Helen Durrant

5

1 reference

19 December 2017

Jim Furniss

6

1 reference

19 December 2017

publication date

1 January 2009

1 reference

19 December 2017

Scandinavian Journal of Urology and Nephrology

published in

1 reference

19 December 2017

volume

43

1 reference

19 December 2017

issue

3

1 reference

19 December 2017

page(s)

192-198

1 reference

19 December 2017

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

A second-look TUR in T1 transitional cell carcinoma: why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Hexyl aminolevulinate fluorescence cystoscopy: new diagnostic tool for photodiagnosis of superficial bladder cancer--a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Guidelines on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Management of patients with Bacilli Calmette-Guérin-refractory carcinoma in situ of the urinary bladder: cost implications of a clinical trial for valrubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365590902808541

10.1080/00365590902808541

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017